Stay updated on SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial

Sign up to get notified when there's something new on the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a background site maintenance update and does not modify study content.
    Difference
    0.1%
    Check dated 2026-03-12T01:45:56.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the older maintenance notices (including Revision: v3.4.1) as part of a minor site update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:30:26.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding lapse notice banner was added and the site revision tag updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T10:38:11.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Show glossary option added. QC metadata updated to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', replacing the previous labels 'Last Update Submitted that met QC Criteria' and 'Revision: v3.3.4', and capitalization adjusted for 'No FEAR Act Data'.
    Difference
    0.2%
    Check dated 2026-01-28T06:34:15.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-14T03:24:27.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Strovolos is now listed as a study location under Locations, and the Strovolos Locations entry has been removed. The page revision is updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T20:45:00.000Z thumbnail image

Stay in the know with updates to SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page.